Page 7 - Antipsychotics News Today

Persistent hiccups can impact a patients quality of life when not adequately treated, according to a survey of cancer care clinicians.

The FDA will temporarily not enforce certain clozapine REMS program requirements to ensure continuity of care for patients taking the antipsychotic.

A new review of antipsychotic trials finds that the placebo response rate is steadily increasing and drug response is decreasing.

Antipsychotics become less effective as estrogen levels drop, making women with schizophrenia more vulnerable to relapse as they age, new research shows.

A novel agent that combines xanomeline and trospium (KarXT) provides clinically meaningful benefits in schizophrenia, new results from the phase 3 EMERGENT-2 trial suggest.

Once considered uninspiring, dopamines reputation as a neurotransmitter has soared. But that doesnt mean we fully understand the so-called pleasure molecule.

A new study has found a strong association between antipsychotic drugs and higher rates of severe cases of COVID-19.

A woman developed an open bite when she took the atypical antipsychotic aripiprazole, and it worsened as the dosage increased, according to a report.

Study finds that of those fully recovered from a first episode of schizophrenia, those who were off antipsychotic drugs had better outcomes.

New research published in the July issue of The Journal of Clinical Psychiatry found that the use of mood stabilizers, antipsychotics, antidepressants, and hypnotics during pregnancy is associated with increased health risks to the infant.